Financial News

Medtronic buys sinus-implant company for over $1 billion

Intersect ENT (NASDAQ: XENT) makes implants that open sinus passageways and deliver an anti-inflammatory steroid to help patients who suffer from chronic rhinosinusitits (CRS).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback